JPH06253780A - Defecation-promoting food - Google Patents
Defecation-promoting foodInfo
- Publication number
- JPH06253780A JPH06253780A JP5045422A JP4542293A JPH06253780A JP H06253780 A JPH06253780 A JP H06253780A JP 5045422 A JP5045422 A JP 5045422A JP 4542293 A JP4542293 A JP 4542293A JP H06253780 A JPH06253780 A JP H06253780A
- Authority
- JP
- Japan
- Prior art keywords
- molecular weight
- defecation
- dietary fiber
- alginate
- food
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 29
- 235000010443 alginic acid Nutrition 0.000 claims abstract description 47
- 229920000615 alginic acid Polymers 0.000 claims abstract description 47
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims abstract description 21
- 229940072056 alginate Drugs 0.000 claims abstract description 21
- 150000002148 esters Chemical class 0.000 claims abstract description 20
- 235000013361 beverage Nutrition 0.000 claims abstract description 14
- 235000013325 dietary fiber Nutrition 0.000 abstract description 30
- 150000004781 alginic acids Chemical class 0.000 abstract description 24
- 229960001126 alginic acid Drugs 0.000 abstract description 23
- 239000000783 alginic acid Substances 0.000 abstract description 23
- 230000013872 defecation Effects 0.000 abstract description 20
- 230000000694 effects Effects 0.000 abstract description 18
- 230000001737 promoting effect Effects 0.000 abstract description 12
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 22
- 239000000661 sodium alginate Substances 0.000 description 22
- 235000010413 sodium alginate Nutrition 0.000 description 22
- 229940005550 sodium alginate Drugs 0.000 description 22
- 230000000968 intestinal effect Effects 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical class N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 9
- 230000001105 regulatory effect Effects 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 5
- 239000008141 laxative Substances 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 241000199919 Phaeophyceae Species 0.000 description 4
- 229910021529 ammonia Inorganic materials 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 238000005227 gel permeation chromatography Methods 0.000 description 4
- 230000009931 harmful effect Effects 0.000 description 4
- 235000013402 health food Nutrition 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- 229940125722 laxative agent Drugs 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000186000 Bifidobacterium Species 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- -1 alkali metal salt Chemical class 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000002550 fecal effect Effects 0.000 description 3
- 210000003608 fece Anatomy 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 235000015110 jellies Nutrition 0.000 description 3
- 239000008274 jelly Substances 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 229920001542 oligosaccharide Polymers 0.000 description 3
- 150000002482 oligosaccharides Chemical class 0.000 description 3
- 229940068196 placebo Drugs 0.000 description 3
- 239000000902 placebo Substances 0.000 description 3
- 235000011962 puddings Nutrition 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 150000004666 short chain fatty acids Chemical class 0.000 description 3
- 239000008143 stimulant laxative Substances 0.000 description 3
- 208000005623 Carcinogenesis Diseases 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000036952 cancer formation Effects 0.000 description 2
- 231100000504 carcinogenesis Toxicity 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 102000038379 digestive enzymes Human genes 0.000 description 2
- 108091007734 digestive enzymes Proteins 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 230000003871 intestinal function Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000002475 laxative effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- PJVXUVWGSCCGHT-ZPYZYFCMSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;(3s,4r,5r)-1,3,4,5,6-pentahydroxyhexan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO PJVXUVWGSCCGHT-ZPYZYFCMSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- IAJILQKETJEXLJ-SQOUGZDYSA-N L-guluronic acid Chemical compound O=C[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O IAJILQKETJEXLJ-SQOUGZDYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 235000015197 apple juice Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- AEMOLEFTQBMNLQ-UHFFFAOYSA-N beta-D-galactopyranuronic acid Natural products OC1OC(C(O)=O)C(O)C(O)C1O AEMOLEFTQBMNLQ-UHFFFAOYSA-N 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- AEMOLEFTQBMNLQ-YBSDWZGDSA-N d-mannuronic acid Chemical compound O[C@@H]1O[C@@H](C(O)=O)[C@H](O)[C@@H](O)[C@H]1O AEMOLEFTQBMNLQ-YBSDWZGDSA-N 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000005118 dietary health Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 1
- 150000003271 galactooligosaccharides Chemical class 0.000 description 1
- 210000003736 gastrointestinal content Anatomy 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 244000005709 gut microbiome Species 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 208000007386 hepatic encephalopathy Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 150000002772 monosaccharides Chemical group 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000015205 orange juice Nutrition 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 229940124513 senna glycoside Drugs 0.000 description 1
- 229930186851 sennoside Natural products 0.000 description 1
- IPQVTOJGNYVQEO-KGFNBKMBSA-N sennoside A Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC2=C1C(=O)C1=C(O)C=C(C(O)=O)C=C1[C@@H]2[C@H]1C2=CC(C(O)=O)=CC(O)=C2C(=O)C2=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C=CC=C21 IPQVTOJGNYVQEO-KGFNBKMBSA-N 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 235000021391 short chain fatty acids Nutrition 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
Landscapes
- Non-Alcoholic Beverages (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
(57)【要約】
【構成】 平均分子量1万〜10万の水溶性アルギン酸塩
またはエステルを含有する排便促進効果を有する食品。
好適には、アルギン酸塩またはエステルを1〜20重量%
含有する飲料である。
【効果】 低分子量化したアルギン酸を使用しても、食
物繊維としての機能を十分に発揮させ排便促進効果が得
られる。従来の高分子量のアルギン酸と異なり、低分子
量化により食品としての利用範囲が広がり、特に飲料と
して、これまで得られなかった濃度のものを飲みやすい
低粘度で得られる。(57) [Summary] [Structure] A food having a defecation promoting effect, which comprises a water-soluble alginate or ester having an average molecular weight of 10,000 to 100,000.
Preferably 1 to 20% by weight of alginate or ester.
It is a contained beverage. [Effects] Even when alginic acid having a low molecular weight is used, the function as a dietary fiber is sufficiently exerted and a defecation promoting effect is obtained. Unlike conventional high-molecular-weight alginic acid, the low-molecular weight makes it possible to broaden the range of applications as foods, and in particular, it is possible to obtain beverages having a concentration not heretofore obtained with a low viscosity that is easy to drink.
Description
【0001】[0001]
【産業上の利用分野】本発明は水溶性アルギン酸塩また
はエステルを有効成分として含有することを特徴とする
排便促進食品に関し、詳しくは平均分子量として1万〜
10万の水溶性アルギン酸塩またはエステルを含有する保
健食品に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a defecation-promoting food containing a water-soluble alginate or ester as an active ingredient. More specifically, it has an average molecular weight of 10,000 to 10,000.
It relates to a health food containing 100,000 water-soluble alginates or esters.
【0002】[0002]
【従来の技術】排便を促進し慢性便秘等に伴う種々の症
状を改善するために即効性があるのは刺激性下剤である
が、刺激性下剤は続けて服用すると効かなくなったり、
排便のコントロールができないという欠点を有する。一
方、食物繊維等の膨化性下剤(膨潤性下剤)は安全であ
るが作用が弱い。BACKGROUND OF THE INVENTION It is stimulant laxatives that have immediate effects in order to promote defecation and improve various symptoms associated with chronic constipation, etc., but stimulant laxatives may not work if taken continuously,
It has the drawback of not being able to control bowel movements. On the other hand, swelling laxatives such as dietary fiber (swelling laxatives) are safe but weak in action.
【0003】食物繊維の摂取による整腸効果は従来より
知られている。食物繊維は消化管において消化・吸収さ
れないため糞便量が増加し、蠕動運動が亢進される。こ
の時、腸内内容物の腸内通過時間が短縮するため、腸管
内、特に大腸にて生成される腐敗産物や発癌物質の生成
が減少し、かつ腸管膜と接触する時間が減少するため発
癌が抑制されることも知られている。The intestinal regulating effect of ingesting dietary fiber has been known for a long time. Since dietary fiber is not digested or absorbed in the digestive tract, the amount of feces increases and peristaltic movement is enhanced. At this time, since the transit time of the intestinal contents into the intestine is shortened, the production of putrefaction products and carcinogens produced in the intestinal tract, especially in the large intestine is reduced, and the time of contact with the intestinal tract membrane is reduced. Is also known to be suppressed.
【0004】食物繊維は人の消化酵素で分解されない難
消化性高分子成分であるとされてきたが、なかには人の
腸内に存在する細菌群により資化、分解される繊維があ
る。特に、高分子量の食物繊維を低分子量化して可溶性
にすると、腸内細菌により資化、分解されやすくなる。
食物繊維の種類によっては、ヒトの腸内に生息している
ビフィズス菌を増殖させる効果を有するものもあり、こ
のような場合は、酢酸や乳酸の生成量が増加する結果、
便通が改善するとされている。また、ビフィズス菌が増
殖することにより有害菌の増殖が抑制されたり、免疫機
能の亢進により大腸内での発癌が抑制するといわれ、有
用である。しかし、食物繊維が有害菌に利用されて腸管
宿主に悪影響を与える物質が産生されることになるので
あれば、本来の整腸効果としては好ましくない。また、
食物繊維の過剰摂取によりミネラルの体内吸収抑制等の
弊害もある。このように、単に食物繊維であれば整腸効
果がある、また、多量に摂取すれば効果が上がるという
ものではない。Dietary fiber has been considered to be an indigestible polymer component that is not decomposed by human digestive enzymes. Among them, there are fibers that are assimilated and decomposed by bacterial groups present in the human intestine. In particular, when a high-molecular weight dietary fiber is made to have a low molecular weight to be soluble, it is easily assimilated and decomposed by intestinal bacteria.
Depending on the type of dietary fiber, there is also one that has the effect of growing Bifidobacteria that live in the human intestine, and in such cases, as a result of the increased production of acetic acid and lactic acid,
It is said that bowel movements will improve. Further, it is said that the growth of bifidobacteria suppresses the growth of harmful bacteria and the promotion of immune function suppresses carcinogenesis in the large intestine, which is useful. However, if dietary fiber is used by harmful bacteria to produce a substance that adversely affects the intestinal host, it is not preferable as the original intestinal regulating effect. Also,
Excessive intake of dietary fiber also has harmful effects such as suppression of absorption of minerals in the body. Thus, simply dietary fiber does not have the effect of regulating the intestine, and ingestion of a large amount does not improve the effect.
【0005】そこで、食物繊維を少量摂取するだけで、
充分な整腸作用を発現させようとする研究が進められて
いる。特開昭63−63366 号公報の記載のオリゴ糖と可食
性食物繊維から成る健康食品は、3〜10個の単糖単位か
らなるオリゴ糖を3〜15%、食物繊維を3〜30%含有
し、オリゴ等によるビフィズス菌増殖効果と、食物繊維
の整腸、便通効果の相乗効果を目的としている。また、
可溶性食物繊維およびガラクトオリゴ糖を併用すること
により、腸内環境を改善し、腐敗産物を低下減少させ、
肝性脳症、大腸癌の治療・予防となる食品や医薬品とし
ての利用を考えた腸内環境改善用組成物 (特開平3−15
1854号) がある。同様にセルロースとフラクトオリゴ糖
からなる便秘改善、便通促進、便性改善用組成物 (特開
平1−319421号) は腎不全による透析患者の便通改善を
目的としている。これらは何れも分子量の小さいオリゴ
糖と分子量の大きい食物繊維を併用している。Therefore, by ingesting a small amount of dietary fiber,
Studies are underway to develop a sufficient intestinal function. The health food consisting of oligosaccharide and edible dietary fiber described in JP-A-63-63366 contains 3 to 15% of oligosaccharide consisting of 3 to 10 monosaccharide units and 3 to 30% of dietary fiber. However, it is intended to have a synergistic effect of the bifidobacteria-proliferating effect of oligo and the like and the intestinal regulating and defecation effects of dietary fiber. Also,
By combining soluble dietary fiber and galacto-oligosaccharides, it improves the intestinal environment, reduces and reduces spoilage products,
A composition for improving the intestinal environment, which is intended to be used as a food or a medicine for treating / preventing hepatic encephalopathy and colon cancer (JP-A-3-15)
1854). Similarly, a composition comprising cellulose and fructooligosaccharide for improving constipation, facilitating bowel movement, and improving fecal property (JP-A-1-319421) aims at improving bowel movement in dialysis patients due to renal failure. Each of these uses a combination of oligosaccharides having a small molecular weight and dietary fiber having a large molecular weight.
【0006】褐藻類より抽出して得られるアルギン酸も
食物繊維としての機能を有することが知られている。ア
ルギン酸はD−マンヌロン酸(以下Mと称する)および
L−グルロン酸(以下Gと称する)からなる共重合体の
ポリウロニド多糖で、褐藻類の細胞間に充填されてお
り、その含量やM/G比および配列順序は種属、季節、
藻体の部位により異なっている。褐藻類から炭酸ナトリ
ウム水溶液等で抽出して得られるアルギン酸は通常高分
子量であり、また水溶液とするためにはナトリウム塩等
のアルカリ金属塩として使用する。水溶性の高分子量ア
ルギン酸塩は、サイジング剤、食品加工、塗料など多方
面に用途がある他、ヒトの消化酵素では分解されない食
物繊維としての機能があり、保健上多くの効用があるこ
とが知られている。しかし、アルギン酸は水に難溶でゲ
ル化しやすく、水溶性としたアルギン酸ナトリウムなど
の塩も数%以上、例えば2%の濃度でゲル化するため、
希薄溶液としてしか使用できず、その利用範囲は限られ
ている。It is known that alginic acid obtained by extracting from brown algae also has a function as dietary fiber. Alginic acid is a polyuronide polysaccharide, which is a copolymer of D-mannuronic acid (hereinafter, referred to as M) and L-guluronic acid (hereinafter, referred to as G), and is packed between cells of brown algae. The ratios and sequence order are species, season,
It depends on the location of the alga. Alginic acid obtained by extraction from brown algae with an aqueous solution of sodium carbonate or the like usually has a high molecular weight, and it is used as an alkali metal salt such as a sodium salt to form an aqueous solution. It is known that water-soluble high-molecular-weight alginate has many uses in sizing agents, food processing, paints, etc. It also has a function as dietary fiber that is not decomposed by human digestive enzymes, and has many health benefits. Has been. However, alginic acid is poorly soluble in water and easily gels, and water-soluble salts such as sodium alginate also gel at a concentration of several% or more, for example, 2%.
It can only be used as a dilute solution and its range of use is limited.
【0007】高分子量のアルギン酸ナトリウムの弛緩性
便秘患者に対する下剤効果については、井上幹夫、守田
則一、佐伯嘉久、診療と新薬、19(5) 、1211 (1982) に
記載されている。アルギン酸ナトリウムは膨化性下剤と
して作用することが知られているが、アルギン酸ナトリ
ウム単独の少量の投与では排便促進の効果が弱いため、
刺激性下剤であるセンノシドA・Bと高分子量アルギン
酸ナトリウムを併用することが検討された。また高分子
量アルギン酸ナトリウムだけでは使用量を増加すると下
痢を誘発しやすいことが判明した。The laxative effect of high molecular weight sodium alginate on flaccid constipation patients is described in Mikio Inoue, Noriichi Morita, Yoshihisa Saeki, Jikken and Shinyaku, 19 (5), 1211 (1982). It is known that sodium alginate acts as a bulking laxative, but administration of a small amount of sodium alginate alone has a weak effect of promoting defecation,
The combined use of sensitizing laxatives sennoside AB with high molecular weight sodium alginate was investigated. It was also found that high molecular weight sodium alginate alone is likely to induce diarrhea when the amount used is increased.
【0008】このように、従来の排便促進食品や下剤で
は、食物繊維のみでは作用が穏やかすぎ、多量に摂取す
ると下痢を誘発したり、ミネラルの体内吸収抑制が生じ
たり、摂取しにくかったりするので、他の低分子量成分
や刺激性下剤を組み合わせて、食物繊維の摂取量が少な
くても整腸効果等を発現させるものが多い。また、藻類
由来の食物繊維であるアルギン酸を用いる場合、そのま
までは高分子量であるため、水溶性の塩としても水に対
する溶解度が非常に低く、またゲル化するため、飲料と
しては 0.1〜1%程度の非常に希薄な溶液で利用するし
かなかった。このような低濃度では食物繊維として必要
な量を飲料で摂取しようとすると多量の飲用が必要であ
る。また、ゼリーやプリン等として用いても、これまで
ゲル化剤として使用されていた1〜2%程度を添加しう
るにとどまり、食物繊維としてのアルギン酸の摂取を目
的とするような量 (例えば5%) では食品の口当たりや
食感が損なわれるため配合できなかった。As described above, in conventional defecation-promoting foods and laxatives, the action of dietary fiber alone is too mild, and ingestion of a large amount causes diarrhea, suppresses absorption of minerals into the body, or is difficult to ingest. In many cases, other low molecular weight components and stimulant laxatives are combined to produce the intestinal regulating effect and the like even when the intake amount of dietary fiber is small. In addition, when alginic acid, which is a dietary fiber derived from algae, is used as it is, it has a high molecular weight, so its solubility in water is very low even as a water-soluble salt, and it gels. It had to be used as a very dilute solution of. At such a low concentration, it is necessary to drink a large amount in order to ingest the required amount of dietary fiber as a beverage. Further, even when used as jelly or pudding, it is only possible to add about 1 to 2% which has been used as a gelling agent so far, and an amount intended to ingest alginic acid as dietary fiber (for example, 5 %) Could not be blended because the mouthfeel and texture of the food were impaired.
【0009】[0009]
【発明が解決しようとする課題】本発明の目的は、食物
繊維としてのアルギン酸を利用して、十分な排便促進効
果を有する食品を提供することである。また、さらに、
これまで利用範囲が限られていた高分子量のアルギン酸
の利用範囲を広げ、アルギン酸の排便促進食品としての
利用を容易にすること、特に飲料としての利用し易さを
図ることを目的とする。An object of the present invention is to provide a food having a sufficient defecation promoting effect by utilizing alginic acid as a dietary fiber. In addition,
The purpose of the present invention is to broaden the range of use of high molecular weight alginic acid, which has been limited until now, to facilitate the use of alginic acid as a food for promoting defecation, and particularly to facilitate the use thereof as a beverage.
【0010】[0010]
【課題を解決するための手段】本発明者らは、通常高分
子量のまま使用されているアルギン酸塩またはエステル
を、平均分子量1万〜10万の低分子量とすることによ
り、溶解度を増加させかつ粘度を低下させてアルギン酸
の利用範囲を広げると共に、十分な排便促進効果を有し
かつ副作用のない排便促進食品を提供しうることを見い
だした。Means for Solving the Problems The present inventors have increased solubility by making alginate or ester, which is usually used in a high molecular weight, into a low molecular weight having an average molecular weight of 10,000 to 100,000. It was found that it is possible to provide a defecation-promoting food having a sufficient defecation-promoting effect and no side effects, while lowering the viscosity and expanding the range of use of alginic acid.
【0011】本発明は、平均分子量1万〜10万の水溶性
アルギン酸塩またはエステルを含有することを特徴とす
る排便促進食品を要旨とする。この食品の好適態様とし
ては、平均分子量1万〜10万の水溶性アルギン酸塩また
はエステルを1〜20%含有する飲料がある。The gist of the present invention is a defecation-promoting food containing a water-soluble alginate or ester having an average molecular weight of 10,000 to 100,000. A preferred embodiment of this food is a beverage containing 1 to 20% of a water-soluble alginate or ester having an average molecular weight of 10,000 to 100,000.
【0012】[0012]
【作用】以下、本発明の構成をその作用とともに詳述す
る。本発明で用いる、平均分子量1万〜10万のアルギン
酸塩またはエステルは、従来より利用されてきた藻類由
来の高分子量アルギン酸の塩またはエステルを酵素分解
や酸による加水分解、加圧熱水分解等により処理して低
分子量化したもののうち平均分子量1万〜10万を有する
ものである。また、褐藻類より抽出して得られたアルギ
ン酸のうち平均分子量1万〜10万の低分子量のものも使
用できる。低分子量化の方法としては加圧熱水処理がア
ルギン酸を選択的に所望の分子量範囲まで分解できる点
で望ましい。なお、ここで平均分子量とは、プルランを
標準物質としてゲルパーミエーションクロマトグラフィ
ー (GPC)により測定した重量平均分子量である。The structure of the present invention will be described in detail below together with its operation. The alginate or ester having an average molecular weight of 10,000 to 100,000 used in the present invention is a salt or ester of a high molecular weight alginic acid derived from algae which has been conventionally used, but is enzymatically decomposed or hydrolyzed by an acid, hot hydrolyzed under pressure, It is one having an average molecular weight of 10,000 to 100,000 among those treated by. Further, among alginic acids obtained by extracting from brown algae, low molecular weight ones having an average molecular weight of 10,000 to 100,000 can also be used. As a method for lowering the molecular weight, pressurized hot water treatment is preferable because it can selectively decompose alginic acid to a desired molecular weight range. The average molecular weight is the weight average molecular weight measured by gel permeation chromatography (GPC) using pullulan as a standard substance.
【0013】水溶性アルギン酸塩としてはアルギン酸の
ナトリウム塩、カリウム塩、アンモニア塩等が、またエ
ステルとしてはプロピレングリコールエステルが例示で
きる。アルギン酸塩またはエステルの平均分子量を1万
〜10万とするのは、1万より低いとアルギン酸の食物繊
維としての機能を発揮させ十分な排便促進効果を得られ
ず、10万を超えると飲料とした場合の粘度が増加し、ゲ
ル化するためである。Examples of the water-soluble alginate include sodium salt, potassium salt and ammonia salt of alginic acid, and examples of the ester include propylene glycol ester. When the average molecular weight of alginate or ester is 10,000 to 100,000, if it is lower than 10,000, the function of alginic acid as a dietary fiber is not exerted to obtain a sufficient defecation promoting effect, and if it exceeds 100,000, it becomes a beverage. This is because the viscosity in the case of doing so increases and gels.
【0014】高分子量アルギン酸は食物繊維として人体
への有害物質の排除促進作用、整腸作用等の機能を有す
ることが知られていたが、前述のような性質により利用
形態や含有量が自ずから限られ、また排便促進効果につ
いても単独では十分なものではなかった。It has been known that high molecular weight alginic acid has a function of promoting elimination of harmful substances to the human body as a dietary fiber, a function of regulating intestinal function, etc. However, due to the above-mentioned properties, its use form and content are naturally limited. The effect of promoting defecation was not sufficient by itself.
【0015】前述のように高分子量のアルギン酸の排便
促進効果は弱く、多量の摂取では下痢やミネラル等の体
内吸収抑制の副作用がある。またある程度の排便促進効
果を達成するために例えば2g程度摂取しようとする
と、そのままでの飲用では口内に粘り付き嚥下に困難を
伴う。また飲料として1回で摂取するには2重量%濃度
のものが必要であるが、この濃度の水溶液では粘度が 5
00〜600 センチポイズとなる。飲みやすいのは粘度が 1
00センチポイズ以下であるが、このような粘度にするに
は低い含有量の飲料しか製造できず、必要量を摂取する
には多量に飲用することになる。市販の高分子量アルギ
ン酸ナトリウムを低分子量化した具体例を以下に示す。As described above, the defecation-promoting effect of high molecular weight alginic acid is weak, and ingestion of a large amount thereof has a side effect of suppressing in vivo absorption of diarrhea and minerals. If, for example, about 2 g is ingested in order to achieve a defecation-promoting effect, sticking in the mouth causes difficulty in swallowing. In addition, it is necessary to have a 2% by weight concentration as a beverage to be taken once, but an aqueous solution of this concentration has a viscosity of 5%.
It becomes 00-600 centipoise. Easy to drink has a viscosity of 1
Although it is less than 00 centipoise, only a low content beverage can be produced to achieve such a viscosity, and a large amount is consumed to obtain the required amount. Specific examples of low molecular weight commercially available high molecular weight sodium alginate are shown below.
【0016】(実験例1 〜7)ジャイアント・ケルプから
製造された市販アルギン酸ナトリウム5gと水95gとを
よく混合してからオートクレーブに入れた。表1に示す
条件下でこのアルギン酸塩を熱処理して分解させた。オ
ートクレーブ内の圧力は、使用温度条件下での自生圧力
であり、処理温度100 ℃の場合で約0.1 kg/cm2 G、130
℃では約2kg/cm2 Gであった。熱処理終了後、得られた
低分子量化アルギン酸ナトリウムの溶液から採取した試
料を用いて、GPC(ゲル・パーミエーションクロマト
グラフィー)法により生成物の平均分子量を、また回転
粘度計により30℃における溶液粘度を測定した。Experimental Examples 1 to 7 5 g of a commercially available sodium alginate produced from Giant Kelp and 95 g of water were thoroughly mixed and then put into an autoclave. The alginate was heat-treated and decomposed under the conditions shown in Table 1. The pressure inside the autoclave is the autogenous pressure under operating temperature conditions, and is approximately 0.1 kg / cm 2 G, 130 at a processing temperature of 100 ° C.
It was about 2 kg / cm 2 G at ° C. After the heat treatment was completed, the average molecular weight of the product was measured by GPC (gel permeation chromatography) using the sample collected from the solution of the low molecular weight sodium alginate obtained, and the solution viscosity at 30 ° C was measured by the rotational viscometer. Was measured.
【0017】(実験例8)アルギン酸ナトリウム10gと
水90gを使用して実験例6を繰り返した。Experimental Example 8 Experimental Example 6 was repeated using 10 g of sodium alginate and 90 g of water.
【0018】(比較例)比較例として、未処理アルギン
酸ナトリウムの分子量および粘度を測定した結果を表1
に示した。Comparative Example As a comparative example, the results of measuring the molecular weight and viscosity of untreated sodium alginate are shown in Table 1.
It was shown to.
【0019】[0019]
【表1】 [Table 1]
【0020】このように、分子量270 万のアルギン酸ナ
トリウムを加圧下での熱処理により低分子量化すること
ができる。未処理のアルギン酸ナトリウムでは5.2 〜5.
3 %の濃度で26,500cPと非常に粘度が高く、飲料とはな
らない。これに対し、分子量1万〜10万の本発明で用い
るアルギン酸ナトリウムの粘度は1〜20cPと低かった。As described above, sodium alginate having a molecular weight of 2.7 million can be reduced in molecular weight by heat treatment under pressure. 5.2-5 for untreated sodium alginate.
It has a very high viscosity of 26,500 cP at a concentration of 3% and is not a drink. On the other hand, the viscosity of sodium alginate having a molecular weight of 10,000 to 100,000 used in the present invention was as low as 1 to 20 cP.
【0021】本発明による平均分子量が1万〜10万のア
ルギン酸塩またはエステルを使用すると、従来必要とさ
れてきた食物繊維量5〜6g/日より少ない摂取量で排
便促進効果が発現する。しかもこの低分子量の水溶性ア
ルギン酸塩またはエステルはヒトの腸内菌叢の構成には
変化を及ぼさないが、アンモニアのような腸内腐敗産物
を減少させる。このことは、特開平3−209331号公報に
記載されているトウモロコシ外皮由来の水溶性食物繊維
と同様に、発癌に関与していると考えられる腸内細菌由
来の諸酵素の活性を抑制していると推定される。このよ
うに、腸内細菌叢を変化させず、腸内腐敗産物を減少さ
せることは、腸内環境への影響が小さくて済む利点があ
る。When the alginate or ester having an average molecular weight of 10,000 to 100,000 according to the present invention is used, a defecation promoting effect is exhibited with an intake amount lower than the conventionally required dietary fiber amount of 5 to 6 g / day. Moreover, this low molecular weight water-soluble alginate or ester does not alter the composition of the human intestinal flora, but it reduces intestinal spoilage products such as ammonia. This suppresses the activity of various enzymes derived from intestinal bacteria that are considered to be involved in carcinogenesis, like the water-soluble dietary fiber derived from corn hulls described in JP-A-3-209331. Presumed to be present. Thus, reducing intestinal spoilage products without changing the intestinal microflora has an advantage that the intestinal environment is less affected.
【0022】本発明の排便促進食品は、上記範囲の低分
子量のアルギン酸塩またはエステルとして一日2g以上
摂取すれば排便促進の効果が期待できる。好ましくは2
〜5g摂取すればよい。The defecation-promoting food of the present invention can be expected to have an effect of promoting defecation by ingesting 2 g or more per day of an alginate or ester having a low molecular weight in the above range. Preferably 2
You should take ~ 5g.
【0023】この食品を飲料の形態で用いるには、平均
分子量1万〜10万のアルギン酸塩またはエステルを1〜
20重量%濃度含有するように、水または果汁その他の適
当な飲用液体に溶解する。1重量%以下では、好ましい
量を摂取するのに多量飲むことになり、また20重量%以
上では飲料としては粘度が高すぎる。好ましい濃度は2
〜5重量%である。To use this food in the form of a beverage, 1 to 100 parts by weight of an alginate or ester having an average molecular weight of 10,000 to 100,000 is used.
It is dissolved in water or fruit juice or other suitable drinking liquid to a concentration of 20% by weight. If it is less than 1% by weight, a large amount is consumed to ingest a preferable amount, and if it is more than 20% by weight, the viscosity is too high as a beverage. The preferred concentration is 2
~ 5% by weight.
【0024】また、本発明の食品は飲料に限らず、ゼリ
ーやプリン等の形態で使用することもできる。この場合
1〜5重量%の添加でも食品の物性やテキスチャーに影
響することなく製造できる。従来の高分子量アルギン酸
では、ゼリーやプリン等に配合すると、少量でも食品の
物性に与える影響が大きいため、多量配合することは不
可能であった。本発明の低分子量アルギン酸塩またはエ
ステルは粉末の形態でも使用可能であり、スティック状
食品として一定量の水または温水に溶解して飲用するこ
ともできる。また、この粉末を他の食品、例えばケーキ
を焼く際に添加することもできる。The food of the present invention is not limited to beverages, but can be used in the form of jelly or pudding. In this case, even if added in an amount of 1 to 5% by weight, it can be produced without affecting the physical properties and texture of food. When conventional high molecular weight alginic acid is blended with jelly, pudding or the like, even if a small amount thereof has a great influence on the physical properties of foods, it has been impossible to blend it in a large amount. The low molecular weight alginate or ester of the present invention can be used in the form of a powder, and can also be dissolved in a certain amount of water or warm water as a stick-shaped food for drinking. The powder can also be added when baking other foods, for example cakes.
【0025】本発明の排便促進食品には、常法に従い通
常用いられる香料、甘味料、着色料、保存料その他の各
種添加物等を添加することができる。また、保健食品と
しての機能を高めるために、他の食物繊維や健康増進物
(例えばヨード、鉄分など)を1種もしくは2種以上添
加することも可能である。To the defecation-promoting food of the present invention, various kinds of additives such as flavors, sweeteners, colorants, preservatives and the like which are usually used in accordance with a conventional method can be added. In addition, in order to enhance the function as a health food, other dietary fiber and health enhancer
It is also possible to add one kind or two or more kinds (for example, iodine, iron, etc.).
【0026】[0026]
【実施例】実験例により本発明の低分子量アルギン酸塩
の排便促進作用を実証し、実施例により本発明食品の具
体例を示す。[Examples] Experimental examples demonstrate the defecation-promoting effect of the low molecular weight alginate of the present invention, and Examples show specific examples of the food of the present invention.
【0027】実験例A 健常な女性 (19〜63歳) 26人を投与群18人、プラセボ群
8人の2群に分け、一週間毎の排便日数と排便回数を調
べた。投与群には2gの低分子量アルギン酸ナトリウム
(平均分子量: 5万) を配合したドリンクを朝食後と昼
食後の2回摂取させた。プラセボ群にはアルギン酸ナト
リウムを配合しない以外は投与群と同じ組成のドリンク
を摂取させた。調査期間は4週間とし、ドリンク投与前
1週間および投与中3週間とした。その結果、表2に示
すように投与群で排便日数および排便回数ともに投与前
に比較し、有意に増加した。なお、投与前における排便
日数および回数については、プラセボ群と投与群の間で
有意差検定の結果、有意差がないことが判明した。 Experimental Example A 26 healthy women (19 to 63 years old) were divided into two groups, 18 in the administration group and 8 in the placebo group, and the number of defecation days and the number of defecations per week were examined. 2 g of low molecular weight sodium alginate for the administration group
A drink containing (average molecular weight: 50,000) was ingested twice after breakfast and after lunch. The placebo group was given a drink having the same composition as the administration group except that sodium alginate was not added. The study period was 4 weeks, 1 week before the administration of the drink and 3 weeks during the administration. As a result, as shown in Table 2, the number of defecation days and the number of defecations in the administration group were significantly increased as compared with those before the administration. Regarding the number of days and number of defecation before administration, there was no significant difference as a result of the significant difference test between the placebo group and the administration group.
【0028】[0028]
【表2】 [Table 2]
【0029】また、上記の投与群の中で便秘気味のヒト
を選別して有意差検定を行った結果、以下の表3に示す
ように日数および回数ともに有意差が認められた。In addition, as a result of selecting significant humans having constipation in the above-mentioned administration groups and performing a significant difference test, as shown in Table 3 below, significant differences in both the number of days and the number of times were recognized.
【0030】[0030]
【表3】 [Table 3]
【0031】実験例B 健常な成人男子 (22〜46歳) 6人に実験例Aで使用した
本発明品ドリンクを一日2回 (アルギン酸ナトリウムと
して一日4g) 2週間投与し、投与前1回、投与中2
回、投与中止後1回の合計4回糞便を採取し、糞便菌
叢、pH、アンモニア含量、短鎖脂肪酸量を測定した。そ
の結果を表4に示す。 Experimental Example B Six healthy adult males (aged 22 to 46) were administered the drink of the present invention used in Experimental Example A twice a day (4 g / day as sodium alginate) for 2 weeks, and before administration 1 2 times during administration
A total of 4 times of feces were collected, one time after administration and one time after discontinuation, and fecal flora, pH, ammonia content, and short chain fatty acid content were measured. The results are shown in Table 4.
【0032】低分子量化したアルギン酸ナトリウムを投
与すると、総菌数やビフィズス菌数には影響を及ぼさな
いが、アンモニア含量が減少する傾向にあった。また、
pHや短鎖脂肪酸組成は試験期間中変化しなかった。Administration of low molecular weight sodium alginate did not affect the total number of bacteria or the number of Bifidobacterium, but the ammonia content tended to decrease. Also,
The pH and short-chain fatty acid composition did not change during the test period.
【0033】なお、糞便菌叢の解析は光岡の方法 (「腸
内菌の世界−嫌気性菌の分離と同定」、冬至書房新社、
1984) 、糞便中のアンモニア含量は「アンモニア−テス
トワコー」 (和光純薬製) を使用して測定した。短鎖脂
肪酸は脂肪酸ラベル化キット(YMC製) を使用し、液
体クロマトグラフィーで分析した。The analysis of the fecal flora is performed by Mitsuoka (“The world of intestinal bacteria-isolation and identification of anaerobic bacteria”, Fuyusho Shobo Shinsha,
1984), the ammonia content in feces was measured using "Ammonia-Test Wako" (manufactured by Wako Pure Chemical Industries, Ltd.). Short-chain fatty acids were analyzed by liquid chromatography using a fatty acid labeling kit (YMC).
【0034】[0034]
【表4】 [Table 4]
【0035】以上の実験結果から、本発明の低分子量ア
ルギン酸塩またはエステルは排便促進食品素材として有
用である。From the above experimental results, the low molecular weight alginate or ester of the present invention is useful as a food material for promoting defecation.
【0036】(実施例)本発明の低分子量アルギン酸塩を
使用して下記処方の保健食品を調製した。 例1 平均分子量5万のアルギン酸ナトリウム 20g クエン酸 2g 還元麦芽糖水飴 60g 果糖ぶどう糖液糖 60g 以上に水を加えて全量を1000ml とした。Example A health food having the following formulation was prepared using the low molecular weight alginate of the present invention. Example 1 Sodium alginate having an average molecular weight of 50,000 20 g Citric acid 2 g Reduced maltose starch syrup 60 g Fructose glucose syrup 60 g Water was added to make the total amount 1000 ml.
【0037】 例2 平均分子量3万のアルギン酸ナトリウム 50g クエン酸ナトリウム 5g リンゴ果汁 10g ハチミツ 5g 以上に水を加えて全量を1000ml とした。Example 2 Sodium alginate having an average molecular weight of 30,000 50 g Sodium citrate 5 g Apple juice 10 g Honey 5 g Water was added to the above to make a total volume of 1000 ml.
【0038】 例3 平均分子量1万のアルギン酸ナトリウム 50g クエン酸 1g クエン酸ナトリウム 5g オレンジ果汁 10g ハチミツ 5g 以上に水を加えて全量を1000ml とした。Example 3 Sodium alginate having an average molecular weight of 10,000, 50 g, citric acid, 1 g, sodium citrate, 5 g, orange juice, 10 g, honey, 5 g.
【0039】 例4 平均分子量5万のアルギン酸ナトリウム 20g 粉砂糖 160g バター 160g 小麦粉 160g 卵 4個 以上を混合し、180 ℃のオーブンに入れ途中で160 ℃に
降温し、焼き上げた。Example 4 Sodium alginate having an average molecular weight of 50,000 20 g Powdered sugar 160 g Butter 160 g Wheat flour 160 g Eggs 4 or more were mixed and put in an oven at 180 ° C., and the temperature was lowered to 160 ° C. and baked.
【0040】[0040]
【発明の効果】以上詳述したように、特定範囲にある低
分子量化したアルギン酸を使用すると、従来必要とされ
た食物繊維摂取量より少ない量で、しかも他の整腸効果
を有する成分と併用しなくても十分な排便改善効果のあ
る食品を提供できる。すなわち、水溶性のアルギン酸塩
またはエステルのうち、平均分子量が1〜10万のアルギ
ン酸を摂食すると、便秘傾向のあるヒトの排便状態が改
善され、また下痢を起こすような副作用も生じない。As described above in detail, when a low-molecular weight alginic acid in a specific range is used, it is used in an amount smaller than the conventionally required intake of dietary fiber and in combination with other components having an intestinal regulating effect. It is possible to provide a food product having a sufficient defecation improving effect without doing so. That is, when alginic acid having an average molecular weight of 1 to 100,000 among water-soluble alginates or esters is ingested, the defecation state of humans having a tendency of constipation is improved, and side effects such as diarrhea do not occur.
【0041】また、アルギン酸の低分子量化により、食
感を損なうことなく必要量のアルギン酸を食品中に含有
させることができ、十分な排便促進効果を有する食品を
種々の形態で提供できる。特に飲料とした場合、これま
で得られなかった2〜5重量%程度の濃度の飲料を低粘
度で飲みやすくできるので、上記排便促進食品の好まし
い一形態となる。Further, by lowering the molecular weight of alginic acid, the required amount of alginic acid can be contained in the food without impairing the texture, and foods having a sufficient defecation promoting effect can be provided in various forms. In particular, when used as a beverage, a beverage having a concentration of about 2 to 5% by weight, which has not been obtained up to now, can be easily drinkable with a low viscosity, which is a preferable form of the defecation-promoting food.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 山岸 喬 大阪市中央区北浜4丁目5番33号 住友金 属工業株式会社内 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Takashi Yamagishi 4-53-3 Kitahama, Chuo-ku, Osaka City Sumitomo Metal Industries, Ltd.
Claims (2)
酸塩またはエステルを含有することを特徴とする排便促
進食品。1. A defecation-promoting food containing a water-soluble alginate or ester having an average molecular weight of 10,000 to 100,000.
酸塩またはエステルを1〜20%含有する飲料の形態であ
る請求項1記載の排便促進食品。2. The defecation-promoting food according to claim 1, which is in the form of a beverage containing 1 to 20% of a water-soluble alginate or ester having an average molecular weight of 10,000 to 100,000.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5045422A JPH06253780A (en) | 1993-03-05 | 1993-03-05 | Defecation-promoting food |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5045422A JPH06253780A (en) | 1993-03-05 | 1993-03-05 | Defecation-promoting food |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH06253780A true JPH06253780A (en) | 1994-09-13 |
Family
ID=12718844
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5045422A Pending JPH06253780A (en) | 1993-03-05 | 1993-03-05 | Defecation-promoting food |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH06253780A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009149621A (en) * | 2007-11-30 | 2009-07-09 | Kao Corp | Gip secretion inhibitor |
-
1993
- 1993-03-05 JP JP5045422A patent/JPH06253780A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009149621A (en) * | 2007-11-30 | 2009-07-09 | Kao Corp | Gip secretion inhibitor |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5270058B2 (en) | Inulin products with improved nutrition | |
US5283076A (en) | Algin-containing food and beverage | |
JP5535456B2 (en) | A biological function-improving composition comprising dietary fiber and a rare sugar. | |
CN1105506C (en) | Carbohydrate mixture | |
AU2003262600B2 (en) | Novel use of carbohydrates and compositions | |
EP0382355B1 (en) | Growth promoting agent for bacteria containing pullulan with or without dextran | |
TWI392496B (en) | Composition having effect of treating, preventing, or improving diabetes or diabetic complication and drink comprising the same | |
JP2010254702A (en) | Composition containing viscous fiber and viscosity lowering protein | |
JP2005513077A (en) | Matrix-forming composition containing pectin | |
JP2639726B2 (en) | Water-soluble dietary fiber and method for producing the same | |
JP3553866B2 (en) | Composition based on mannooligosaccharides | |
US20090275530A1 (en) | Gastric Raft Composition Comprising Preferably Processed Starches For Inducing Satiety | |
US7147883B1 (en) | Compositions containing at least one polyol and inulin characterized by reduced tendencies of the at least one polyol to induce acute diarrhea | |
JPH03151854A (en) | Composition for improving intestinal environment | |
JP3720496B2 (en) | Novel pectin and emulsion containing the same | |
JPH02248401A (en) | Low-molecular guar gum, its production and food and drink containing same | |
JP2004159659A (en) | Composition mainly composed of mannooligosaccharide | |
JP3996679B2 (en) | Lipid metabolism improver | |
JP3008138B2 (en) | Intestinal environment improving agent containing guar gum enzymatic degradation product as active ingredient | |
JP2978332B2 (en) | Intestinal metabolism improving food and intestinal metabolism improving agent | |
JPWO2005056022A1 (en) | Composition for improving bowel disease | |
JP2019136036A (en) | Liquid food | |
EP1290952B1 (en) | Compositions for taking dietary fibers | |
JPH06253780A (en) | Defecation-promoting food | |
JP4889970B2 (en) | Hyperphosphatemia preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 19991207 |